Morningstar

KBroVet® (potassium bromide chewable tablets) Becomes First FDA Fully Approved Pharmaceutical For The Control of Seizures Associated with Idiopathic Epilepsy in Dogs

PENSACOLA, Fla., Feb. 12, 2026 /PRNewswire/ -- Pegasus Laboratories, Inc. (Pegasus), is pleased to announce, under its registered trademark PRN® Pharmacal, that KBroVet® (potassium bromide chewable ...
Drug Store News

Amneal obtains FDA OK for pyridostigmine bromide ER tablets

Amneal has received the Food and Drug Administration’s approval for pyridostigmine bromide ER tablets, 105 mg. PB ER 105 mg tablets are a once-daily, orally administered product indicated for ...
Nasdaq

Amneal Pharma: FDA Approves NDA For Pyridostigmine Bromide Extended-Release Tablets

(RTTNews) - Amneal Pharmaceuticals (AMRX) announced it has received FDA approval of its New Drug Application for Pyridostigmine Bromide Extended-Release Tablets USP 105 mg. PB ER 105 mg tablets are a ...
Business Wire

Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company based in the U.S., today announced that it has received U.S ...